Bulletin from the annual general meeting of CombiGene AB (publ)
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
The following resolutions were passed at the Annual General Meeting (the “AGM”) of CombiGene AB (publ) (the “Company”) on 23 May 2024 in Stockholm.
Adoption of income statement and balance sheet and discharge from liability
The AGM resolved to adopt the income statement and balance sheet of the Company and the group for the financial year 2023. The AGM also resolved to discharge the members of the Board of Directors and the CEO from liability for their management of the Company’s affairs during the financial year 2023.
Allocation of profit or loss
The AGM resolved, in accordance with the Board of Directors’ proposal, that no dividend shall be paid for 2023 and that the results of the Company shall be carried forward.
Board of Directors and auditor
The AGM resolved, in accordance with the shareholder Orphazyme A/S’ proposal, on re-election of Jonas Ekblom, Peter Nilsson, Per Lundin, Gunilla Lundmark and Malin Almgren, and on new election of Marcus Isaksson, as Board members. Jonas Ekblom was re-elected as chairman of the Board of Directors. The AGM re-elected the audit firm Mazars AB as auditor.
The AGM further resolved on remuneration to the Board of Directors in accordance with the Nomination Committee’s proposal. The AGM furthermore resolved in accordance with the Nomination Committee’s proposal, that remuneration to the auditor shall be paid in accordance with approved statement of costs.
Nomination Committee for the next AGM
The AGM resolved, in accordance with the Nomination Committee’s proposal, on principles for the appointment of the Nomination Committee for the next AGM.
Amendment of the Articles of Association
The AGM resolved, in accordance with the Board of Directors’ proposal, to amend the Articles of Association. The amendments entail that the object of the business is changed to better reflect the Company’s current business, that the Board of Directors is allowed to collect proxies in accordance with Chapter 7, Section 4 of the Swedish Companies Act, and that the Board of Directors is given the opportunity to resolve before a general meeting that shareholders shall be able to exercise their voting rights by voting by mail, and that the general meeting may be held digitally.